EMA publishes report on transatlantic collaboration to advance medicines

14 July, 2015

Senior leaders from the United States Food and Drug Administration (FDA), the European Commission and the European Medicines Agency (EMA) reviewed their ongoing cooperative activities, including  veterinary medicines as one of the focus subjects (Link). Specific topics discussed were the one-health concept and novel therapies such as stem cells, oncology products and cytokines.

Business Units: